TransGenRx, a biotech firm that spun off of research at the LSU Ag Center, has signed a $30 million deal to produce human growth hormone for a pharmaceutical company based in Argentina. Cassara will buy the human growth hormone for use in medicines sold in Central and South America and the Middle East, says Richard Cooper, an executive vice president with TransGenRx. Cooper says this is the first contract for TransGenRx, which was founded in 2002. The company produces pharmaceutical proteins. “We’ve been refining our process and getting our techniques for cell culture down,” Cooper says. TransGenRx has 36 full-time employees and 15 student workers. Cooper says he hopes the contract will lead to additional hiring.
TransGenRx signs $30 million deal with Argentinean firm
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
